INS and type 1 diabetes mellitus: Indeed, later studies targeting the B:9–23 insulin epitope presented on I-Ag7 showed that the TCR-like mIgG1 mAb287 delayed disease onset in diabetic NOD mice as an experimental model for type 1 diabetes (T1D) when administered at both early or late stages of disease [81].